The standard playbook for hospital profitability is no longer sufficient, as the industry faces converging challenges that threaten financial stability. From shifting volume and payer-mix, to weakening non-core revenue sources, hospitals must adapt to survive.

Transformative, high-cost therapies and diagnostics can offer patients truly tailored treatment. Gain insight into how personalized therapies are creating a need for new ways to finance and deliver care.

The health insurance industry is undergoing a transformation, with government-sponsored private plans (through Medicare Advantage, Medicaid-managed care, and the individual market) gaining momentum while employer-sponsored insurance stagnates. The scale of the public segments brings more urgency for oversight from regulators — and increases health plans’ sensitivity to program changes.